PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
20.86%
Revenue growth exceeding 1.5x Healthcare median of 2.70%. Joel Greenblatt would investigate if growth quality matches quantity.
17.29%
Cost growth of 17.29% versus flat Healthcare costs. Walter Schloss would verify cost control.
30.04%
Gross profit growth exceeding 1.5x Healthcare median of 0.14%. Joel Greenblatt would investigate competitive advantages.
7.59%
Margin expansion while Healthcare median declines. Peter Lynch would examine competitive advantages.
-60.00%
R&D reduction while Healthcare median is 1.33%. Seth Klarman would investigate competitive implications.
-7.96%
G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.
67.21%
Marketing expense change of 67.21% versus flat Healthcare spending. Walter Schloss would verify adequacy.
132.35%
Other expenses change of 132.35% versus flat Healthcare costs. Walter Schloss would verify efficiency.
122.90%
Operating expenses growth exceeding 1.5x Healthcare median of 2.29%. Jim Chanos would check for waste.
105.50%
Total costs growth while Healthcare reduces costs. Peter Lynch would examine differences.
83.16%
Interest expense change of 83.16% versus flat Healthcare costs. Walter Schloss would verify control.
-80.48%
D&A reduction while Healthcare median is -3.78%. Seth Klarman would investigate efficiency.
-114.58%
EBITDA decline while Healthcare median is 3.90%. Seth Klarman would investigate causes.
-77.54%
EBITDA margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-130.61%
Operating income decline while Healthcare median is 3.90%. Seth Klarman would investigate causes.
-90.81%
Operating margin decline while Healthcare median is 0.77%. Seth Klarman would investigate causes.
130.66%
Other expenses growth while Healthcare reduces costs. Peter Lynch would examine differences.
-75.82%
Pre-tax income decline while Healthcare median is -5.84%. Seth Klarman would investigate causes.
-45.47%
Pre-tax margin decline while Healthcare median is -1.87%. Seth Klarman would investigate causes.
-10502.49%
Tax expense reduction while Healthcare median is 0.16%. Seth Klarman would investigate advantages.
-61.23%
Net income decline while Healthcare median is 4.21%. Seth Klarman would investigate causes.
-33.40%
Net margin decline while Healthcare median is 1.27%. Seth Klarman would investigate causes.
100.00%
EPS growth exceeding 1.5x Healthcare median of 3.59%. Joel Greenblatt would investigate advantages.
100.00%
Diluted EPS growth exceeding 1.5x Healthcare median of 3.59%. Joel Greenblatt would investigate advantages.
-100.00%
Share count reduction while Healthcare median is 0.00%. Seth Klarman would investigate strategy.
-100.00%
Diluted share reduction while Healthcare median is 0.12%. Seth Klarman would investigate strategy.